We are starting our FDA IDE!

Argá Medtech is pleased to announce that the FDA has granted approval to begin the COHERENT AF IDE trial to test the safety and effectiveness of the Coherent Sine Burst Electroporation™ System (CSE) in patients with paroxysmal and persistent atrial fibrillation.

We anticipate enrollments to begin shortly in selected centers across the US and EU.